Summary & Overview
CPT 93582: Transcatheter Closure of Patent Ductus Arteriosus
CPT code 93582 denotes the percutaneous transcatheter closure of a patent ductus arteriosus (PDA), a congenital connection between the pulmonary artery and aorta. This minimally invasive interventional cardiology procedure provides an alternative to open surgical ligation and is significant for reducing recovery time and resource utilization for pediatric and adult congenital heart patients. Nationally, transcatheter PDA closure is an established treatment within congenital heart disease programs and cardiac catheterization laboratories.
Key payers addressed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication covers payer coverage considerations and typical site-of-care configurations for this service across major commercial and public payers.
Readers will find an overview of clinical context for PDA closure, typical sites of service and care settings, common billing modifiers relevant to procedure reporting, and guidance on coding nomenclature. Where available, benchmarking information and policy updates affecting authorization and coverage processes are summarized. Data gaps in the input are noted as unavailable; the content focuses on the procedural description, payer landscape, and operational implications for facilities and billing teams.
Billing Code Overview
CPT code 93582 describes a percutaneous, catheter-based closure of a patent ductus arteriosus (PDA), a congenital vascular connection between the pulmonary artery and the aorta. The procedure is performed by inserting a catheter through the skin and advancing it through the vascular system to deploy a closure device at the PDA, achieving occlusion without an open surgical approach.
Service type: Interventional cardiology procedure — transcatheter PDA closure
Typical site of service: Cardiac catheterization laboratory or interventional radiology suite
Clinical & Coding Specifications
Clinical Context
A typical patient is an infant or young child diagnosed with a hemodynamically significant patent ductus arteriosus (PDA) presenting with signs of congestive heart failure, poor weight gain, tachypnea, or a continuous murmur on exam. The cardiology team schedules a transcatheter device closure under general anesthesia in a pediatric cardiac catheterization laboratory. Vascular access is obtained percutaneously (commonly femoral vein and/or artery), and fluoroscopic and echocardiographic guidance (often transesophageal or transthoracic) is used to cross the ductus, size the defect with angiography, and deploy an occlusion device. Hemodynamic measurements, oxygen saturations, and angiographic runs are performed before device selection. Post-deployment angiography and echocardiography confirm device position and absence of residual shunt or obstruction to adjacent structures. The patient is monitored in a post-anesthesia care unit or pediatric cardiac observation unit for complications such as vascular injury, device embolization, arrhythmia, or hemolysis before discharge or admission for observation. The procedural workflow typically involves the interventional pediatric cardiologist, pediatric cardiac anesthesiologist, catheterization lab nursing and technologist staff, and echocardiography support for intra-procedural imaging.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | Use when billing only the physician’s professional interpretation or supervision portion of a service if separated from technical component. |